» Articles » PMID: 24801346

Technological Preferences of Aging Cancer Patients for Delivery Services and Devices to Solve Drug-related Problems in Oncology

Overview
Specialties Critical Care
Oncology
Date 2014 May 8
PMID 24801346
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To identify the technological preferences of aging cancer patients with regard to the delivery services and devices for preventing/solving three common drug-related problems (DRPs): medication nonadherence, lack of knowledge in medications, and side effects management.

Methods: A survey was conducted at a cancer center from May to August 2011. Delivery services included in the interviewer-administered questionnaire included voice-activated dispensing, voice reminders, electronic messages, helplines, and mobile phone applications, among others. Three devices were proposed-watches, bracelets, and mobile phones. Descriptive statistics and chi-square tests were performed.

Results: A total of 361 surveys were analyzed. Median age of respondents was 61 years. The majority of respondents were female (57.3 %), Chinese (88.9 %), and 65 years and younger (73.4 %). More than half (59.0-63.2 %) were receptive to the use of the delivery services. Patients preferred voice reminder alerts (28.0 %) and electronic messages (17.7 %) to help with their medication nonadherence, and helplines for medications (52.6 %) and side effects management (47.4 %). Higher educated patients were more likely to want delivery services to improve their medication adherence (p = 0.045) and knowledge in medications management (p = 0.050). Middle age patients (age 50-65) were also more likely to want delivery services for the latter DRP (p = 0.009). Among those who wanted delivery services, most preferred mobile phones.

Conclusion: Middle age and elderly cancer patients are accepting of delivery services to help them with their DRPs. With middle aged patients being more receptive of the delivery services, technology can potentially play an important role in minimizing DRPs.

Citing Articles

The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients.

Zhang J, Xu R, Zhao X, Wang Y, Zhu W, Xiao M Transl Cancer Res. 2022; 10(4):1703-1711.

PMID: 35116495 PMC: 8797392. DOI: 10.21037/tcr-20-3164.


Patients' Perception of App-based Educational and Behavioural Interventions for Enhancing Oral Anticancer Medication Adherence.

Ali E, Leow J, Chew L, Yap K J Cancer Educ. 2017; 33(6):1306-1313.

PMID: 28707206 DOI: 10.1007/s13187-017-1248-x.


The Potential Role for Smartphones Among Older Adults with Chronic Noncancer Pain: A Qualitative Study.

Richardson J, Lee J, Nirenberg A, Reid M Pain Med. 2017; 19(6):1132-1139.

PMID: 28108642 PMC: 5998946. DOI: 10.1093/pm/pnw284.


Mobile technologies: expectancy, usage, and acceptance of clinical staff and patients at a university medical center.

Illiger K, Hupka M, von Jan U, Wichelhaus D, Albrecht U JMIR Mhealth Uhealth. 2014; 2(4):e42.

PMID: 25338094 PMC: 4259908. DOI: 10.2196/mhealth.3799.

References
1.
Or C, Karsh B . A systematic review of patient acceptance of consumer health information technology. J Am Med Inform Assoc. 2009; 16(4):550-60. PMC: 2705259. DOI: 10.1197/jamia.M2888. View

2.
Luo N, Koh W, Ng W, Yau J, Lim L, Sim S . Acceptance of information and communication technologies for healthcare delivery: a SingHealth Polyclinics study. Ann Acad Med Singap. 2009; 38(6):529-8. View

3.
Nijland N, van Gemert-Pijnen J, Kelders S, Brandenburg B, Seydel E . Factors influencing the use of a Web-based application for supporting the self-care of patients with type 2 diabetes: a longitudinal study. J Med Internet Res. 2011; 13(3):e71. PMC: 3222177. DOI: 10.2196/jmir.1603. View

4.
Chae Y, Park H, Cho J, Hong G, Cheon K . The reliability and acceptability of telemedicine for patients with schizophrenia in Korea. J Telemed Telecare. 2000; 6(2):83-90. DOI: 10.1258/1357633001935095. View

5.
Hepler C, Strand L . Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47(3):533-43. View